• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸导管切除对食管癌根治术后无复发并存活的患者长期身体成分的影响。

The impact of thoracic duct resection on the long-term body composition of patients who underwent esophagectomy for esophageal cancer and survived without recurrence.

机构信息

Department of Surgery, Keio University School of Medicine, Tokyo, Japan.

Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.

出版信息

Dis Esophagus. 2023 Sep 1;36(9). doi: 10.1093/dote/doad002.

DOI:10.1093/dote/doad002
PMID:37465862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10473448/
Abstract

BACKGROUND

We have reported the possible benefits of radical esophagectomy with thoracic duct (TD) resection in elective esophageal cancer surgery. However, the effect of TD resection on the long-term nutrition status remains unclear.

METHODS

Patients who underwent esophagectomy at Keio University between January 2006 and December 2018 were included, and those who had no recurrence for more than three years were evaluated. Changes in each body composition (muscle mass and body fat) were comparatively assessed between those who underwent TD resection or not, before and at, one, three and five years after surgery. Computed tomography images were analyzed on postoperative year 1, 3 and 5.

RESULTS

This study included 217 patients categorized in the TD-resected (TD-R) (156 patients) and TD-preserved (TD-P) (61 patients) groups. The loss of muscle mass was comparable between the groups. On the other hand, the loss of adipose tissues was significantly greater in the TD-R group than in the TD-P group at one and three years after surgery, while there was no statistical difference five years after surgery. Additionally, among patients with cT1N0M0 disease in whom survival advantage of TD resection has been reported previously, the loss of muscle mass did not differ between each group.

CONCLUSIONS

The change of muscle mass between the two groups was comparable. Although body fat mass was reduced by TD resection, it eventually recovered in the long term. In patients with esophageal cancer, TD resection may be acceptable without significant impact on body composition in the long term.

摘要

背景

我们已经报道了在选择性食管癌手术中根治性食管切除术联合胸导管(TD)切除的可能益处。然而,TD 切除对长期营养状况的影响尚不清楚。

方法

纳入了 2006 年 1 月至 2018 年 12 月期间在庆应义塾大学接受食管切除术的患者,并评估了无复发超过 3 年的患者。比较了接受和未接受 TD 切除的患者在手术前后 1 年、3 年和 5 年时的身体成分(肌肉质量和体脂)变化。术后第一年、第三年和第五年进行计算机断层扫描图像分析。

结果

本研究纳入了 217 例患者,分为 TD 切除(TD-R)组(156 例)和 TD 保留(TD-P)组(61 例)。两组的肌肉质量丢失相当。另一方面,在手术后 1 年和 3 年,TD-R 组的脂肪组织丢失明显大于 TD-P 组,而在手术后 5 年,两组之间没有统计学差异。此外,在先前报道 TD 切除有生存优势的 cT1N0M0 疾病患者中,两组之间的肌肉质量丢失没有差异。

结论

两组之间肌肉质量的变化相当。尽管 TD 切除减少了体脂量,但在长期内它最终会恢复。在食管癌患者中,TD 切除可能是可以接受的,不会对身体成分产生长期的显著影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a31/10473448/7a8f64ba2247/doad002f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a31/10473448/249ea8dba654/doad002f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a31/10473448/365ab360a92d/doad002f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a31/10473448/7a8f64ba2247/doad002f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a31/10473448/249ea8dba654/doad002f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a31/10473448/365ab360a92d/doad002f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a31/10473448/7a8f64ba2247/doad002f3.jpg

相似文献

1
The impact of thoracic duct resection on the long-term body composition of patients who underwent esophagectomy for esophageal cancer and survived without recurrence.胸导管切除对食管癌根治术后无复发并存活的患者长期身体成分的影响。
Dis Esophagus. 2023 Sep 1;36(9). doi: 10.1093/dote/doad002.
2
Nutritional Outcomes of Thoracic Duct Resection for Radical Esophagectomy by Assessing Body Composition Changes in One Year: A Single-Center Retrospective Study.通过评估一年内身体成分变化探讨根治性食管癌切除术中胸导管切除的营养结局:一项单中心回顾性研究
Ann Surg Oncol. 2021 Dec;28(13):8414-8425. doi: 10.1245/s10434-021-10222-8. Epub 2021 Jun 3.
3
Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct.经胸食管切除术联合胸导管切除术的临床结果:清扫淋巴结数量及胸导管周围淋巴结转移分布情况
Medicine (Baltimore). 2016 Jun;95(24):e3839. doi: 10.1097/MD.0000000000003839.
4
Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus-Impact on Lymph Node Yield and Hemodynamic Parameters.新辅助放化疗后行胸导管切除术的微创食管癌切除术——对淋巴结获取量和血流动力学参数的影响
J Gastrointest Cancer. 2019 Jun;50(2):230-235. doi: 10.1007/s12029-018-0051-1.
5
Thoracic Duct Resection During Esophagectomy Does Not Contribute to Improved Prognosis in Esophageal Squamous Cell Carcinoma: A Propensity Score Matched-Cohort Study.胸导管切除术在食管癌中的应用并未改善食管鳞癌患者的预后:一项倾向评分匹配队列研究。
Ann Surg Oncol. 2019 Nov;26(12):4053-4061. doi: 10.1245/s10434-019-07627-x. Epub 2019 Jul 16.
6
Prognosis of Patients with Esophageal Carcinoma After Routine Thoracic Duct Resection: A Propensity-matched Analysis of 12,237 Patients Based on the Comprehensive Registry of Esophageal Cancer in Japan.常规胸导管切除术后食管癌患者的预后:基于日本食管癌综合登记数据库的 12237 例患者倾向性匹配分析。
Ann Surg. 2023 May 1;277(5):e1018-e1025. doi: 10.1097/SLA.0000000000005340. Epub 2023 Apr 6.
7
Thoracic Duct Resection Has a Favorable Impact on Prognosis by Preventing Hematogenous Spread of Esophageal Cancer Cells: A Multi-institutional Analysis of 2269 Patients.胸导管切除术通过预防食管癌细胞血行播散对预后有有利影响:2269 例患者的多机构分析。
Ann Surg Oncol. 2021 Aug;28(8):4402-4410. doi: 10.1245/s10434-021-09962-4. Epub 2021 Apr 16.
8
Oncological and physiological impact of thoracic duct resection in esophageal cancer.胸导管切除对食管癌的肿瘤学和生理学影响。
Dis Esophagus. 2023 Sep 30;36(10). doi: 10.1093/dote/doad015.
9
Effect of Resection of the Thoracic Duct and Surrounding Lymph Nodes on Short- and Long-Term and Nutritional Outcomes After Esophagectomy for Esophageal Cancer.食管癌根治性切除术后胸导管及其周围淋巴结清扫对短期和长期及营养结局的影响。
Ann Surg Oncol. 2019 Jun;26(6):1893-1900. doi: 10.1245/s10434-019-07304-z. Epub 2019 Mar 12.
10
Is Thoracic Duct Resection Necessary for Esophageal Squamous Cell Carcinoma Patients Treated with Neoadjuvant Chemoradiotherapy? A Propensity-Matched Analysis Based on the Comprehensive Registry of Esophageal Cancer in Japan.对于接受新辅助放化疗的食管鳞状细胞癌患者,是否有必要进行胸导管切除术?基于日本食管癌综合登记处的倾向匹配分析。
Ann Surg Oncol. 2023 May;30(5):2691-2698. doi: 10.1245/s10434-022-12891-5. Epub 2022 Dec 18.

引用本文的文献

1
Prognosis of Robot-Assisted Esophagectomy with Thoracic Duct Resection in Esophageal Squamous Cell Carcinoma.机器人辅助食管癌切除术联合胸导管切除术治疗食管鳞状细胞癌的预后
Ann Surg Oncol. 2025 Apr 30. doi: 10.1245/s10434-025-17318-5.
2
Investigating the synergistic effects of immunochemotherapy in esophageal squamous cell carcinoma.研究免疫化疗在食管鳞状细胞癌中的协同作用。
Esophagus. 2025 Apr;22(2):188-197. doi: 10.1007/s10388-025-01113-y. Epub 2025 Feb 18.
3
Application of network analysis and association rule mining for visualizing the lymph node metastasis patterns in esophageal squamous cell carcinoma.

本文引用的文献

1
Prognosis of Patients with Esophageal Carcinoma After Routine Thoracic Duct Resection: A Propensity-matched Analysis of 12,237 Patients Based on the Comprehensive Registry of Esophageal Cancer in Japan.常规胸导管切除术后食管癌患者的预后:基于日本食管癌综合登记数据库的 12237 例患者倾向性匹配分析。
Ann Surg. 2023 May 1;277(5):e1018-e1025. doi: 10.1097/SLA.0000000000005340. Epub 2023 Apr 6.
2
Cancer Cachexia: Its Mechanism and Clinical Significance.癌症恶病质:发病机制及临床意义。
Int J Mol Sci. 2021 Aug 6;22(16):8491. doi: 10.3390/ijms22168491.
3
Effectiveness of lymphadenectomy along the thoracic duct for radical esophagectomy.
网络分析和关联规则挖掘在可视化食管鳞状细胞癌淋巴结转移模式中的应用
Sci Rep. 2025 Feb 13;15(1):5415. doi: 10.1038/s41598-025-89340-2.
4
Robotic esophagectomy with function-preserving radical mediastinal lymphadenectomy for esophageal cancer.机器人食管癌切除术联合保留功能的根治性纵隔淋巴结清扫术治疗食管癌
Ann Gastroenterol Surg. 2024 Sep 11;9(1):12-23. doi: 10.1002/ags3.12862. eCollection 2025 Jan.
5
Impact of Thoracic Duct Resection on Long-Term Survival After Esophagectomy: Individual Patient Data Meta-analysis.胸导管切除对食管癌手术后长期生存的影响:个体患者数据分析荟萃分析。
Ann Surg Oncol. 2024 Oct;31(10):6699-6709. doi: 10.1245/s10434-024-15770-3. Epub 2024 Jul 20.
6
Prevalence and clinical outcomes of sarcopenia in patients with esophageal, gastric or colorectal cancers receiving preoperative neoadjuvant therapy: A meta-analysis.接受术前新辅助治疗的食管癌、胃癌或结直肠癌患者中肌肉减少症的患病率及临床结局:一项荟萃分析。
Asia Pac J Oncol Nurs. 2024 Mar 8;11(4):100436. doi: 10.1016/j.apjon.2024.100436. eCollection 2024 Apr.
7
Oncological and physiological impact of thoracic duct resection in esophageal cancer.胸导管切除对食管癌的肿瘤学和生理学影响。
Dis Esophagus. 2023 Sep 30;36(10). doi: 10.1093/dote/doad015.
胸导管旁淋巴结清扫术在根治性食管癌手术中的疗效。
Esophagus. 2022 Jan;19(1):85-94. doi: 10.1007/s10388-021-00868-4. Epub 2021 Jul 31.
4
Nutritional Outcomes of Thoracic Duct Resection for Radical Esophagectomy by Assessing Body Composition Changes in One Year: A Single-Center Retrospective Study.通过评估一年内身体成分变化探讨根治性食管癌切除术中胸导管切除的营养结局:一项单中心回顾性研究
Ann Surg Oncol. 2021 Dec;28(13):8414-8425. doi: 10.1245/s10434-021-10222-8. Epub 2021 Jun 3.
5
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.新辅助放化疗联合手术治疗食管癌的 10 年结果:随机对照 CROSS 试验。
J Clin Oncol. 2021 Jun 20;39(18):1995-2004. doi: 10.1200/JCO.20.03614. Epub 2021 Apr 23.
6
Thoracic Duct Resection Has a Favorable Impact on Prognosis by Preventing Hematogenous Spread of Esophageal Cancer Cells: A Multi-institutional Analysis of 2269 Patients.胸导管切除术通过预防食管癌细胞血行播散对预后有有利影响:2269 例患者的多机构分析。
Ann Surg Oncol. 2021 Aug;28(8):4402-4410. doi: 10.1245/s10434-021-09962-4. Epub 2021 Apr 16.
7
Minimally invasive oesophagectomy with extended lymph node dissection and thoracic duct resection for early-stage oesophageal squamous cell carcinoma.微创食管切除术联合扩大淋巴结清扫和胸导管切除术治疗早期食管鳞癌。
Br J Surg. 2020 May;107(6):705-711. doi: 10.1002/bjs.11487. Epub 2020 Feb 20.
8
Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma.肌肉减少症作为局部晚期胃食管腺癌患者生存的预后因素。
PLoS One. 2019 Oct 22;14(10):e0223613. doi: 10.1371/journal.pone.0223613. eCollection 2019.
9
Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival.减肥和肌肉减少症对化疗反应、生活质量和生存的影响。
Nutrition. 2019 Nov-Dec;67-68:110539. doi: 10.1016/j.nut.2019.06.020. Epub 2019 Jun 28.
10
Changes in body weight, skeletal muscle and adipose tissue after gastrectomy: a comparison between proximal gastrectomy and total gastrectomy.胃切除术后体重、骨骼肌和脂肪组织的变化:近端胃切除术与全胃切除术的比较
ANZ J Surg. 2019 Jan;89(1-2):79-83. doi: 10.1111/ans.15023. Epub 2019 Jan 31.